Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Cancer Detection and Staging by Extracellular Monitoring of Metabolic Activity Profiles of Peripheral Blood Mononuclear Cells (PBMC)

NCT02090166 is registered in ClinicalTrials.gov with Carmel Medical Center as lead sponsor.

NCT NCT02090166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02090166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Cancer Detection and Staging by Extracellular Monitoring of Metabolic Activity Profiles of Peripheral Blood Mononuclear Cells (PBMC)
Lead sponsor
Carmel Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2014
Completion date
January 31, 2021
Enrollment
950 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer